Cranioplasty Using Titanium Mesh vs Bone Cement

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorOsman Hassan Osman Zafraan

About this trial

The aim of this study is:

To compare the surgical outcomes between titanium mesh and bone cement in cranioplasty.

To assess the complication rates associated with each material. To evaluate patient satisfaction and aesthetic results post-surgery

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients requiring cranioplasty for a skull defect due to Decompressive Craniectomy, trauma, tumor resection, or congenital issues.

All ages .

Both sex.

Informed consent obtained from all participants.

Disqualifiers

Patients with active infection at the surgical site

Patient Unfit for surgery.

Patient refuse consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cranioplasty with Titanium mesh

    Procedure/Surgery

    Cranioplasty using titanium mesh

  • Cranioplasty with bone cement

    Procedure/Surgery

    Cranioplasty using bone cement

Treatment groups

46 Participants
are divided into 2 treatment groups
Group A: Titanium meshActive comparator 1 intervention
Group B: Bone cementActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Patient satisfaction using patient ssatisfaction grade

Patients satisfaction (cosmetic, psychological, neurologic ) measered by validate questionnaire post-opeartive and follow up using Patient satisfaction grade from Excellent to not satisfied

Time frame
through study completion, an average 1 years

Secondary outcomes

1

Infection

follow up rate of post operative infection

Time frame
through study completion, an average 1 years
2

Reoperation

rate of reoperation after using each material a post-operative follow up

Time frame
through study completion, an average 1 years
3

CSF leak

post-operative complication of CSF leak due to changes in Dynamics of CSF flow

Time frame
through study completion, an average 1 years
4

complications

post-operative as hematoma formation , neurologic defict and fits.

Time frame
through study completion, an average 1 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Osman Hassan Osman Zafraan

Lead sponsor

Assiut University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: